Multiple Targeting Approaches on Histamine H3 Receptor Antagonists
With the very recent market approval of pitolisant (Wakix®), the interest in clinical applications of novel multifunctional histamine H3 receptor antagonists has clearly increased. Since histamine H3 receptor antagonists in clinical development have been tested for a variety of different indications...
Main Authors: | Mohammad eKhanfar, Anna eAffini, Kiril eLutsenko, Katarina eNikolic, Stefania eButini, Holger eStark |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-05-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnins.2016.00201/full |
Similar Items
-
Novel chalcone-based fluorescent human histamine H3 receptor ligands as pharmacological tools
by: Holger eStark
Published: (2012-03-01) -
Physiological implications of biased signaling at histamine H2 receptors.
by: Natalia eAlonso, et al.
Published: (2015-03-01) -
Nuclear localization of histamine receptor 2 in primary human lymphatic endothelial cells
by: Sarit Pal, et al.
Published: (2022-07-01) -
Identification of TSPAN4 as Novel Histamine H<sub>4</sub> Receptor Interactor
by: Xiaoyuan Ma, et al.
Published: (2021-07-01) -
Targeted therapy with histamine antagonists - New challenges to fight with breast cancer
by: Piotr Jan Więsyk, et al.
Published: (2022-11-01)